Effective Treatment of Diabetic Kidney Disease with MicroDose at Renew Medical Center
Renew Medical Center leads the way in treating diabetic kidney disease through their innovative MicroDose treatment. Unlike conventional drug-based therapies, MicroDose delivers insulin as a hormone, targeting the root cause of diabetes – metabolic failure. By mimicking natural physiological processes, MicroDose effectively reduces insulin resistance, facilitating the absorption of blood sugar into cells where it is converted into energy. This groundbreaking approach has shown promising results in improving the management of diabetic kidney disease.
How MicroDose Differs from Traditional Therapies for Diabetic Kidney Disease
The MicroDose system (MDS) treatment approach utilizes the “pulse-rest” intervals of insulin production to reactivate alternative insulin-signaling pathways, which can enhance kidney function and potentially reverse kidney tissue damage. Developed in the USA, this treatment option specifically aims to restore the natural insulin cycle observed in healthy individuals. By improving insulin sensitivity, MicroDose therapy offers several benefits for individuals with kidney disease.
One significant benefit is improved blood glucose control. Restoring insulin sensitivity helps maintain proper blood glucose levels, preventing further kidney damage caused by high blood sugar. Additionally, MicroDose treatment may help reduce protein loss, a common issue in kidney disease. By improving insulin sensitivity, this therapy minimizes protein loss and alleviates the progression of kidney disease, thus preventing proteinuria.
Moreover, addressing insulin resistance through MicroDose therapy can help lower blood pressure, reducing the risk of kidney-related complications. By improving insulin sensitivity and managing insulin resistance, this treatment may also provide additional benefits in managing metabolic disorders that contribute to kidney disease, such as obesity and type 2 diabetes.
Customized Care Plans for Optimal Results in Diabetic Kidney Disease Treatment
At Renew Medical Center, we recognize the importance of personalized care for patients with kidney disease. Each patient’s degree of insulin resistance and carbohydrate metabolism efficiency is unique, which is why we begin with a consultation to assess medical necessity and develop an individualized care plan under the guidance of our physicians.
The care plan typically includes an “Induction Phase” consisting of two infusions per week, gradually reducing to one infusion per week over approximately 90 days. This is followed by a “Maintenance Phase” aimed at finding the optimal balance between metabolism and insulin sensitivity, with the goal of extending the time between treatments for as long as possible.
Patients with kidney disease, high blood pressure, type 2 diabetes, prediabetes, and nondiabetic conditions usually start their treatment with three-hour infusions during the Induction Phase. As treatment progresses, infusion duration is typically reduced to two hours, enabling patients to maintain optimized metabolism and insulin sensitivity for four to six weeks between treatments.
If you are seeking MicroDose treatment or would like to learn more about its potential benefits, we encourage you to contact Renew Medical Center. Our dedicated physicians are available to address your queries and schedule personalized consultations.
Bengaluru: +91-886 755 4231
Mumbai: +91-959 486 4331
Hyderabad: +91-800 874 5871
Website: www.renewmed.in
The Revolutionary Approach of Physiological Insulin Sensitivity Restoration with MicroDose Treatment for Diabetic Kidney Disease
